(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide)

C73H91N27O7 — CID 159677371

IUPAC(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide)
SMILESCCCCOC(=O)c1cc(-n2cnc(C(C)(C)C)c2)c(C)cn1.C[C@H](CO)n1nnnc1-c1cccc(N)n1.Cc1cnc(C(=O)Nc2cccc(-c3nnnn3[C@H](C)CO)n2)cc1-n1cnc(C(C)(C)C)c1.Cc1cnc(C(=O)Nc2cccc(-c3nnnn3[C@H](C)CO)n2)cc1-n1cnc(C(C)(C)C)c1
InChIInChI=1S/2C23H27N9O2.C18H25N3O2.C9H12N6O/c2*1-14-10-24-17(9-18(14)31-11-19(25-13-31)23(3,4)5)22(34)27-20-8-6-7-16(26-20)21-28-29-30-32(21)15(2)12-33;1-6-7-8-23-17(22)14-9-15(13(2)10-19-14)21-11-16(20-12-21)18(3,4)5;1-6(5-16)15-9(12-13-14-15)7-3-2-4-8(10)11-7/h2*6-11,13,15,33H,12H2,1-5H3,(H,26,27,34);9-12H,6-8H2,1-5H3;2-4,6,16H,5H2,1H3,(H2,10,11)/t2*15-;;6-/m11.1/s1
InChIKeyMUTSQVWVMOBBES-TVPMRYCHSA-N
MW1458.71 g/mol
LogP9.16
Rot. Bonds20

About (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide)

(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide) (PubChem CID 159677371) has the molecular formula C73H91N27O7 and a molecular weight of 1458.71 g/mol. Its IUPAC name is (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide).

Molecular Properties

Compound Name(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide)
PubChem CID159677371
Molecular FormulaC73H91N27O7
Molecular Weight1458.71 g/mol
Exact Mass1457.76
IUPAC Name(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide)
SMILESCCCCOC(=O)c1cc(-n2cnc(C(C)(C)C)c2)c(C)cn1.C[C@H](CO)n1nnnc1-c1cccc(N)n1.Cc1cnc(C(=O)Nc2cccc(-c3nnnn3[C@H](C)CO)n2)cc1-n1cnc(C(C)(C)C)c1.Cc1cnc(C(=O)Nc2cccc(-c3nnnn3[C@H](C)CO)n2)cc1-n1cnc(C(C)(C)C)c1
InChIInChI=1S/2C23H27N9O2.C18H25N3O2.C9H12N6O/c2*1-14-10-24-17(9-18(14)31-11-19(25-13-31)23(3,4)5)22(34)27-20-8-6-7-16(26-20)21-28-29-30-32(21)15(2)12-33;1-6-7-8-23-17(22)14-9-15(13(2)10-19-14)21-11-16(20-12-21)18(3,4)5;1-6(5-16)15-9(12-13-14-15)7-3-2-4-8(10)11-7/h2*6-11,13,15,33H,12H2,1-5H3,(H,26,27,34);9-12H,6-8H2,1-5H3;2-4,6,16H,5H2,1H3,(H2,10,11)/t2*15-;;6-/m11.1/s1
InChIKeyMUTSQVWVMOBBES-TVPMRYCHSA-N
XLogP9.16
TPSA432.81 Ų
H-Bond Donors6
H-Bond Acceptors32
Rotatable Bonds20
Heavy Atoms107
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001458.71
LogP ≤ 59.16
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide)?
The IUPAC name of (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide) (CID 159677371) is (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide).
What is the SMILES notation for (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide)?
The canonical SMILES for (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide) is CCCCOC(=O)c1cc(-n2cnc(C(C)(C)C)c2)c(C)cn1.C[C@H](CO)n1nnnc1-c1cccc(N)n1.Cc1cnc(C(=O)Nc2cccc(-c3nnnn3[C@H](C)CO)n2)cc1-n1cnc(C(C)(C)C)c1.Cc1cnc(C(=O)Nc2cccc(-c3nnnn3[C@H](C)CO)n2)cc1-n1cnc(C(C)(C)C)c1.
What is the InChIKey of (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide)?
The InChIKey is MUTSQVWVMOBBES-TVPMRYCHSA-N. The full InChI is InChI=1S/2C23H27N9O2.C18H25N3O2.C9H12N6O/c2*1-14-10-24-17(9-18(14)31-11-19(25-13-31)23(3,4)5)22(34)27-20-8-6-7-16(26-20)21-28-29-30-32(21)15(2)12-33;1-6-7-8-23-17(22)14-9-15(13(2)10-19-14)21-11-16(20-12-21)18(3,4)5;1-6(5-16)15-9(12-13-14-15)7-3-2-4-8(10)11-7/h2*6-11,13,15,33H,12H2,1-5H3,(H,26,27,34);9-12H,6-8H2,1-5H3;2-4,6,16H,5H2,1H3,(H2,10,11)/t2*15-;;6-/m11.1/s1.
What are the key properties of (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide)?
(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide) has a molecular weight of 1458.71 g/mol, XLogP of 9.16, 20 rotatable bonds, 6 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;butyl 4-(4-tert-butylimidazol-1-yl)-5-methylpyridine-2-carboxylate;bis(4-(4-tert-butylimidazol-1-yl)-N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-5-methylpyridine-2-carboxamide) is sourced from PubChem (CID 159677371), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).